Company: CMND
Filing Date: 2025-09-17
Form Type: 6-K
Source: 0001213900-25-088566
Chunk: 3

Company: Clearmind Medicine Inc.
Filing Date: 2025-09-17
Form: 6-K
Chunk 3
---
 of such words are intended
to identify forward-looking statements. For example, the Company is using forward-looking statements when it discusses the terms and potential
future issuances of Notes under the SPA and the Company’s intended use of proceeds and its exploration of strategic opportunities.
Forward-looking statements are not historical facts, and are based upon management’s current expectations, beliefs and projections,
many of which, by their nature, are inherently uncertain. Such expectations, beliefs and projections are expressed in good faith. However,
there can be no assurance that management’s expectations, beliefs or projections will be achieved, and actual results may differ
materially from what is expressed in, or indicated by, the forward-looking statements. Forward-looking statements are subject to risks
and uncertainties that could cause actual performance or results to differ materially from those expressed in the forward-looking statements.
For a more detailed description of the risks and uncertainties affecting the Company, reference is made to the Company’s reports
filed from time to time with the SEC, including, but not limited to, the risks detailed in the Company’s Annual Report on Form 20-F
filed on January 22, 2025. Forward-looking statements speak only as of the date the statements are made. The Company assumes no obligation
to update forward-looking statements to reflect actual results, subsequent events or circumstances, changes in assumptions or changes
in other factors affecting forward-looking information except to the extent required by applicable securities laws. If the Company does
update one or more forward-looking statements, no inference should be drawn that the Company will make additional updates with respect
thereto or with respect to other forward-looking statements.

<div align='center'>2

EXHIBIT INDEX</div>

| * | Portions of this exhibit (indicated by asterisks) have been                                                                            
 omitted under rules of the SEC permitting the confidential treatment of select information. The Registrant agrees to furnish a copy of 
 all omitted information to the SEC upon its request                                                                                    |

<div align='center'>3

SIGNATURES</div>

Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto
duly authorized.

| Date: September 17, 2025 | Clearmind Medicine, Inc. 
 (Registrant)             
 By:                      | /s/ Adi Zuloff-Shani    |
|:-------------------------|:-------------------------|:------------------------|
|                          | Name